E
Elisabetta Bezzon
Publications - 13
Citations - 442
Elisabetta Bezzon is an academic researcher. The author has contributed to research in topics: Mammography & Digital mammography. The author has an hindex of 6, co-authored 12 publications receiving 402 citations.
Papers
More filters
Journal ArticleDOI
Digital breast tomosynthesis versus digital mammography: a clinical performance study
Gisella Gennaro,Alicia Toledano,Cosimo di Maggio,Enrica Baldan,Elisabetta Bezzon,Manuela La Grassa,Luigi Pescarini,Ilaria Polico,Alessandro Proietti,Aida Toffoli,Pier Carlo Muzzio +10 more
TL;DR: Clinical performance of tomosynthesis in one view at the same total dose as standard screen-film mammography is not inferior to digital mammography in two views.
Journal ArticleDOI
Performance comparison of single-view digital breast tomosynthesis plus single-view digital mammography with two-view digital mammography.
Gisella Gennaro,R. Edward Hendrick,Patricia Ruppel,Roberta Chersevani,Cosimo di Maggio,Manuela La Grassa,Luigi Pescarini,Ilaria Polico,Alessandro Proietti,Enrica Baldan,Elisabetta Bezzon,Fabio Pomerri,Pier Carlo Muzzio +12 more
TL;DR: Breast tomosynthesis (DBT) has emerged as a valuable adjunct to mammography (MX) in terms of ROC curve area, sensitivity and specificity and was superior to two-view MX in recognising benign lesions.
Journal ArticleDOI
Combination of one-view digital breast tomosynthesis with one-view digital mammography versus standard two-view digital mammography: per lesion analysis
Gisella Gennaro,R. Edward Hendrick,Alicia Toledano,Jean R. Paquelet,Elisabetta Bezzon,Roberta Chersevani,Cosimo di Maggio,Manuela La Grassa,Luigi Pescarini,Ilaria Polico,Alessandro Proietti,Enrica Baldan,Fabio Pomerri,Pier Carlo Muzzio +13 more
TL;DR: This study shows that readers’ capabilities in detecting and characterizing breast lesions are improved by combining single- view digital breast tomosynthesis and single-view mammography compared to two-view digital mammography.
Journal ArticleDOI
First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
Anna Roma,Marco Maruzzo,Umberto Basso,Antonella Brunello,Rita Zamarchi,Elisabetta Bezzon,Fabio Pomerri,Stefania Zovato,Giuseppe Opocher,Vittorina Zagonel +9 more
TL;DR: Sunitinib may achieve a fairly good disease control in VHL patients, andRadiological responses may be obtained not only in renal tumors but also in synchronous VHL-related lesions, especially pancreatic solid nodules whose exact nature cannot be ruled out without invasive biopsy.
Journal ArticleDOI
Immunotherapy and urothelial carcinoma: An overview and future prospectives
Francesco Pierantoni,Marco Maruzzo,Mario Gardi,Elisabetta Bezzon,Marina Paola Gardiman,Angelo Porreca,Umberto Basso,Vittorina Zagonel +7 more
TL;DR: Strong evidence supports the use of CPIs after failure of Cisplatin-based chemotherapy, although no predictive parameter is available so far, and neoadjuvant trials with CPIs and trials combining two CPIs are promising and will further expand theUse of immunotherapy.